Recent studies have underscored the critical role of the cGAS-STING pathway in anti-tumor immunity, particularly in lung cancer, where its activation significantly enhances immune activity within the tumor microenvironment, thereby suppressing tumor growth and metastasis 8, 13. This evidence concerns the gene STING1 and lung cancer.